top of page

Search Results

Results found for "pain modeling"

  • Artificial intelligence – faster, smarter, cheaper GPCR drug discovery

    ML algorithms typically use traditional ML models, such as decision trees and support vector machines While classical ML models are effective for datasets for which the relevant features are well understood which comprise handcrafted features and simpler models. For this reason, DL models generally require more computational resources (such as powerful GPUs) and Classification: AI models can be used to distinguish GPCRs from non-GPCRs, and to classify GPCRs into

  • GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors

    Dopamine D2 receptor modulators  – transforming treatment for Parkinson’s & schizophrenia. Allosteric modulation  for unprecedented precision. Serotonin & dopamine receptor modulation  for neuropsychiatric disorders. These sessions bridge structural biology , computational modeling , and clinical translation  — with

  • 📰 GPCR Weekly News, July 31 to August 6, 2023

    GPCR Symposium on 'GPCRs as Therapeutic Modalities' is set for September 22nd. Neuroscience Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson's disease mouse model diseases Ultrasensitive dose-response for asbestos cancer risk implied by new inflammation-mutation model the GPCR Smoothened and to the germline inducer Oskar Industry News Addex GABAb Positive Allosteric Modulator

  • GRK2 in cardiovascular disease and its potential as a therapeutic target

    Additionally, GPCR dysregulation underlies multiple models of cardiac pathology, and most pharmacological Current literature strongly establishes increased levels and activity of GRK2 in multiple models of CVD the GRK2 interactome includes numerous proteins which interact with differential domains of GRK2 to modulate the ongoing and future research for targeting this critical kinase across cellular, animal and human models

  • The Perils and Guardrails of Modifying Signalling Proteins in Bioassays

    This limited detection and modelling of 5-HT2AR-Gιi/o coupling could mistakenly divert attention from and Gιi1, respectively (Figure 2B), as well as different coupling preferences between specific Gβγ pairs Allosteric modulation of G protein-coupled receptor signaling. Endogenous allosteric modulators of G protein-coupled receptors. delta opioid receptors is an endogenous mechanism and therapeutic target for relief from inflammatory pain

  • How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision

    Must-read publications:  A structural modeling study revealing non-canonical mechanisms of chemokine-driven From t-test, ANOVA, F-test selection to power analysis  that prevents underpowered studies, this module Gain career inspiration from Ajay’s bold questions and pivots.

  • Drug Discovery Picks Up the Pace, Stays on Target

    They include small molecules that conditionally modulate proteins in their functional state; three-dimensional (3D) cell models, or organoid models, that assist with target identification, high-throughput drug screening

  • Orthosteric Binding Experiments: How to Avoid the Most Common Data Pitfalls

    In this session, you’ll gain: Why saturation and displacement assays fail when protein stoichiometry The midpoint and maximum—core parameters for downstream modeling—are only meaningful when the assay fully Unexpected outcomes typically trace back to a single issue: transferring assumptions from idealized models This frequently masquerades as: Two binding sites Multiple receptor subtypes Allosteric modulation But

  • Breaking the Myth of High and Low Affinity Sites

    In this session, you’ll gain:   ✅ A framework for understanding when apparent multiple affinities really Are You Using Models That Slow You Down?   Join Now — Access Immediate, Actionable Insight   You’ll gain the insight needed to:   Interpret complex

  • Exploring the Breakthroughs in GPCR Research

    research on the Relevance of GPCR dynamics for receptor activation, signalling bias and allosteric modulation G protein-coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation Comprehensive Conformational Rearrangements of a G Protein-Coupled Receptor Influence of the Water Model Interactions of the GPR40 Protein with the Lipid Membrane and the Solvent: Rigid versus Flexible Water Models

  • 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024

    Gain access to over 500 minutes of recorded classes in our  GPCR courses   taught by Drs. signalling profiles GPCRs in Cardiology, Endocrinology, and Taste Cyclic adenosine monophosphate critically modulates of fingolimod (FTY720) and desensitization of S1P1 receptor-mediated G-protein activation in a mouse model Methods & Updates in GPCR Research GPCRSPACE: A New GPCR Real Expanded Library Based on Large Language Models

  • 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⌿ Nov 18 - 24, 2024

    Alexander S Hauser GPCRdb in 2025: adding odorant receptors, data mapper, structure similarity search and models anti-inflammatory drug binds at two distinct sites of a human bitter taste GPCR Photo-BQCA: Positive Allosteric Modulators Enabling Optical Control of the M1 Receptor The cell adhesion molecule CD44 acts as a modulator of 5 pharmacogenomics research GPCRdb in 2025: adding odorant receptors, data mapper, structure similarity search and models

  • 📰 GPCR Weekly News, March 13 to 19, 2023

    A Rab10-ACAP1-Arf6 GTPases cascade modulates M4 muscarinic acetylcholine receptor trafficking and signaling Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator. Îą1-adrenoceptor A small molecule ligand for the novel pain target, GPR171, produces minimal reward in mice. Endogenous l- to d-amino acid residue isomerization modulates selectivity between distinct neuropeptide

  • Assay Volume Control: Your GPCR Drug Discovery Power Lever

    Breakthroughs this week: C. elegans avoids EGCG via SRXA-7 GPCR; a bidirectional GPCR switch modulates We kick off with a question that cuts deep: What if your models could actually predict the future? Jens Carlsson  (Uppsala University) joins Yamina  to explore how computational modeling is evolving from

  • Do You Believe AI Could Accelerate Drug Discovery?

    Lyu et al. prospectively docked ultra-large libraries of molecules against unrefined AF2 models of the They found that AF2 models achieved accurate side-chain predictions and successfully docked high-affinity Docking 490 million molecules against the σ2 receptor's AF2 model yielded a 54% hit rate, comparable Moreover, advanced AI models like AlphaFold3, which can predict complex protein-molecule interactions This proprietary nature limits direct access to the model and imposes a cap on daily predictions.

  • Community guidelines for GPCR ligand bias: IUPHAR review 32

    August 2022 "GPCRs modulate a plethora of physiological processes and mediate the effects of one-third requires that we now characterize physiological signalling not just by receptors but by ligand-receptor pairs implementation of the guidelines, together improving translation from in vitro to disease-relevant in vivo models

  • Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery

    (Bikker et al., 1998) Quantitative studies of how drugs modulate their targets have been instrumental Integrating mutagenesis data with computational models also presents challenges, requiring high-quality contributions, challenges such as data complexity, resource intensity, and integration with computational models G-protein coupled receptors: models, mutagenesis, and drug design.

  • Knowing When to Walk, Knowing When to Run: Lessons from the Bench

    A Final Aha Moment: Try the Crazy Idea When a collaborator offered a neuroma model (one where opioids Keyword Cloud: GPCR online course, early-career scientists, imposter syndrome, GPCR podcast, neuroma model

  • Identification of hub genes in the subacute spinal cord injury in rats

    The models of the three gene expression profiles were all for SCI to the thoracic segment of the rat. Module analysis was performed using Cytoscape.

  • Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future

    preclinical data supports the applicability of CB2 activation in autoimmune and inflammatory diseases, pain

  • Developing the Cannabinoid Receptor 2 (CB2) pharmacopeia: past, present, and future

    preclinical data support the applicability of CB2 activation in autoimmune and inflammatory diseases, pain

  • The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think

    from new pipelines targeting obesity to significant collaborations in cardiometabolic disease, and gain Terry's Corner - Unlock the Power of Target Residence Time in Your GPCR Drug Discovery Pipeline Gain Threat Avoided:  Prevent costly late-stage failures by incorporating kinetic modeling early in your pipeline Problem Solved:  Gain a deeper understanding of the pharmacological underpinnings of opioid overdose, GPCR University Course Attendee Ready to gain a competitive advantage?

  • The regulation of PKA signaling in obesity and in the maintenance of metabolic health

    hormones, neurotransmitters and other signaling molecules that bind G-protein coupled receptors (GPCR) to modulate Mouse models have provided invaluable information on the roles for PKA subunits in brain and key metabolic

  • 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024

    , for their work on Isoquinoline small molecule ligands are agonists and probe-dependent allosteric modulators Pacific abalone Haliotis discus hannai GPCR Binders, Drugs, and more Photo-BQCA: Positive Allosteric Modulators of the M1 Receptor Isoquinoline small molecule ligands are agonists and probe-dependent allosteric modulators LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease models

  • Constitutive, Basal, and β-Alanine-Mediated Activation of the Human Mas-Related G Protein-Coupled ..

    coupled receptors (MRGPRs), a subfamily of GPCRs, are largely expressed by sensory neurons and known to modulate itch and pain.

  • 📰 GPCR Weekly News, February 6 to 12, 2023

    Isoform- and ligand-specific modulation of the adhesion GPCR ADGRL3/Latrophilin3 by a synthetic binder Binders, Drugs, and more An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models Quantitative analysis of sterol-modulated monomer-dimer equilibrium of the β1-adrenergic receptor by pulls off rare IPO, raising $161M 3-drug combo leads to 'unprecedented' response in pancreatic cancer models

  • Precise druggability of the PTH type 1 receptor

    prototypic class B GPCR target, and a combination of molecular dynamics simulations and elastic network model-based Here we found a key mechanical site that modulates the collective dynamics of the receptor and used this This study provides a computational pipeline to detect precise druggable sites and identify allosteric modulators

  • Sweet taste receptor agonists attenuate macrophage IL‐1β expression and eosinophilic inflammation...

    macrophage IL‐1β overproduction, thereby suggesting autophagy regulation as a potential therapeutic modality therapeutic effects of trehalose and saccharin on macrophage IL‐1β production and eosinophilia in the mouse model

  • A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.

    and has synergistic effects with anticancer agents.[1–3] These insights highlight the potential in modulating Translational Potential of Allosteric Modulators Targeting the Cannabinoid CB1 Receptor. for Neuropathic Pain Relief. A.; Bazin, H.; Tinel, N.; Durroux, T.; Prézeau, L.; Trinquet, E.; Pin, J.-P. Derivatives as New CB2 Cannabinoid Receptors Agonists: Synthesis, Pharmacological Properties and Molecular Modeling

  • 📰 GPCR Weekly News, March 4 to 10, 2024

    Gain invaluable skills in data analysis under Dr. Hoare's expert guidance. Receptors GPCRs in Neuroscience A M1 muscarinic acetylcholine receptor-specific positive allosteric modulator Alzheimer disease revealed by genomic analysis restricted to variants impacting gene function Interaction modes spectroscopy Up-regulation of GPR139 in the medial septum ameliorates cognitive impairment in two mouse models

bottom of page